25 LLC’s Labcorp LH Stock Holding History

25 LLC’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-2	Closed	-$424	–	304
2023 Q2	$424	Buy	+2	New	+$388	﹤0.01%	594

Other funds holding LH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

25 LLC's LH Position: Q3 2023 in Review

25 LLC sold out of Labcorp (LH) in Q3 2023, closing a stake of 2 shares — an estimated $424 sold.

25 LLC first reported a position in LH in Q2 2023 and held it in 1 quarter. The position peaked at $424 in Q2 2023. 881 funds tracked by Wall St. Rank hold LH as of Q3 2023.

25 LLC reported no remaining Labcorp position as of Q3 2023 after selling out during the quarter.
25 LLC sold 2 Labcorp shares in Q3 2023, an estimated $424.
25 LLC first reported a position in Labcorp in Q2 2023 and held it in 1 quarter.
25 LLC's Labcorp position peaked at $424 in Q2 2023.
881 funds tracked by Wall St. Rank held Labcorp as of Q3 2023.

Based on 25 LLC's 13F filing for Q3 2023, filed 18 Oct 2023.